With a 5.98% market share, India is the fourth-largest pharmaceutical supplier to the U.S., behind Ireland, Switzerland, and ...

Federal regulators are caught between old-guard conservatives who demand continued mRNA funding, Rep. Massie's demand to ...

The federal government’s decision to slash $500 million in funding for mRNA vaccine research has sparked concern among health ...

The Score is a weekly review of the biggest stock moves and the news that drove them. Here is this week's installment: ...

An official overseeing implementation of the Make America Healthy Again agenda at the Department of Health and Human Services ...

Intel has stood by Tan, and in a statement told The Wall Street Journal that its board and management were aligned on strategy. Before Trump jumped into the fray, Tan was already at odds with some of ...

The tussle had centred on the development of mRNA jab technology, which was at the forefront of the fight against Covid-19.

The growing healthcare burden posed by hepatocellular carcinoma, the most common subtype of liver cancer, has prompted the ...

GSK said it will receive $370 million as part of the U.S. patent settlement involving CureVac and BioNTech over mRNA-based COVID-19 vaccines, The Wall Street Journal reported Aug. 8. Under the deal, ...

Pima County health officials say fall vaccine supplies remain steady despite changes in federal research funding.

So-called mRNA vaccines saved millions of lives during the COVID-19 pandemic — and now scientists are using that Nobel Prize-winning technology to try to develop vaccines and treatments against a ...

CSL Seqirus was one of the drugmakers the federal government listed this week as having its mRNA-related work cut. In an ...